Research Progress of Baihe Gujin Decoction in the Treatment of Lung Cancer

References

• Shi XM, Liu W, Gao SJ. The relationship between inflammatory markers and lung cancer. J Moder Oncol. 2010;18(12):2501–2505.
   Google Scholar
• Wang DY, Yan B, Tian GQ. Traditional Chinese medicine treatment for primary bronchogenic carcinoma: an overview of clinical researches in past five years. J Traditional Chin Med. 2021;62(18):1643–1647.
   Google Scholar
• Li N, Tian SD, Dong Q, Lv QY, Chen XY. Professor Chen Xinyi′s clinical experience in the treatment of non-small cell lung cancer with traditional Chinese Medicine. World J Integr Trad West Med. 2022;17(12):2397–2400.
   Google Scholar
• Lv XX. Immunotherapy: a life-saving weapon for lung cancer patients. Health Life. 2019;7:43–44.
   Google Scholar
• Wang Q, Sun F, Shan YB, Shi HC. Progress of diagnosis and treatment of immune-associated pneumonitis in immunotherapy for lung cancer. J Clin Pulm Med. 2023;28(3):436–440.
   Google Scholar
• He JX, Yue XY. Progress of comprehensive treatment for small-cell lung cancer. Oncol Progre. 2020;18(21):2169–2172.
   Google Scholar
• Xia B, Jiang H, Wang LM, et al. Progress of clinical research on lung cancer in the past 30 years. J Pract Oncol. 2016;31(4):296–300.
   Google Scholar
• Wei Z, Chen J, Zuo F, et al. Traditional Chinese Medicine has great potential as candidate drugs for lung cancer: a review. J Ethnopharmacol. 2023;300:115748.
   PubMed Web of Science ®Google Scholar
• Xu LM, Hu YY. 脂肪肝的中药治疗 [Studies on treatment of fatty liver with traditional Chinese medicine]. Zhong Xi Yi Jie He Xue Bao. 2003;1(2):138–141. Chinese.
   PubMedGoogle Scholar
• Bian LJ, Liu ZG, Li GX. Promoting health wellness-The essentials of Chinese medicine. Chin J Integr Med. 2015;21(8):563–568.
   PubMed Web of Science ®Google Scholar
• Koithan M, Wright C. Promoting optimal health with traditional Chinese medicine. J Nurse Pract. 2010;6(4):306–307.
   PubMedGoogle Scholar
• Matos LC, Machado JP, Monteiro FJ, Greten HJ. Understanding traditional Chinese medicine therapeutics: an overview of the basics and clinical applications. Healthcare. 2021;9(3):257.
   Web of Science ®Google Scholar
• Xu LG, Bai W, Wang QW, et al. Role of acupuncture in amblyopia treatment. Altern Ther Health Med. 2021;27(4):50–53.
   PubMed Web of Science ®Google Scholar
• Li YY, Jia XW, Guo LZ. Exploration on pathological factors of lung cancer. J Liaoning Univ Traditional Chin Med. 2012;14(2):92–93.
   Google Scholar
• Liu N, Zhao WH, Wei XH. Evaluation of the Curative effect of shengmai powder combined with baihe gujin decoction plus or minus in the treatment of qi and yin deficiency lung cancer. Heilongj Med J. 2021;34(3):585–588.
   Google Scholar
• Lei ZX. Progress of research on traditional Chinese medicine in treating lung cancer. Hunan J Trad Chin Med. 2017;33(12):154–156.
   Google Scholar
• Wang SM, Dong ZH, Tu HB, et al. Analysis on Distribution Characteristics of TCM Syndromes in Primary Lung Cancer: a Report of 388 Cases. Acta Universitatis Traditionis Medicalis Sinensis Pharmacologiaeque Shanghai. 2013;27(5):30–34.
   Google Scholar
• Feng F, Feng CL, Zhang L. Correlation between TCM patterns and bronchoscopy manifestation: a pilot study of primary bronchogenic carcinoma patients. J Beiji Univ Trad Chin Med. 2016;39(5):417–423.
   Google Scholar
• Xiong C, He CS, Wang J. Clinical characteristics of Baihe Gujin Decoction in the treatment of lung cancer. Asia-Pacific Tradit Med. 2016;12(17):59–60.
   Google Scholar
• Gu KB, Wang X, He LL, Sun GZ. Brief Analysis on Prof.SUN Gui-zhi′s Common Formulas for Lung Cancer. World J Integr Trad West Med. 2013;8(2):187–189.
   Google Scholar
• Han T. 方剂学 [Prescriptions]. 济南:山东科学技术出版社 [Shangdong Science and Technology Press Co];2020:136.
   Google Scholar
• Wang WL, Xu LH. Overview of research on treatment of chronic respiratory diseases with baihe gujin decoction. J Emergency Traditional Chin Med. 2006;11:1276–1277.
   Google Scholar
• Wang ZK, Wang JT, Zheng YL. Research Progress of Qianjin Weijing Decoction in Treatment of Lung Cancer. Chinese Archives Traditional Chin Med. 2022;3:1–10.
   Google Scholar
• Wu Q, Li D, Sun T. Bai-He-Gu-Jin-Tang formula suppresses lung cancer via AKT/GSK3beta/beta-catenin and induces autophagy via the AMPK/mTORC1/ULK1 signaling pathway. J Cancer. 2021;12(21):6576–6587.
   PubMed Web of Science ®Google Scholar
• Lv XW. Effect and mechanism of modified baihegujing decotion on radiotherapy of NSCLC. Hubei Univ Chin Med. 2018;2:1.
   Google Scholar
• Zhou J, Liu ZG, Tan JL. Mechanism of Baihe Gujin Decoction in the treatment of non-small cell lung cancer. J Hunan Normal Univ. 2021;18(2):8–12.
   Google Scholar
• Liu KL, Deng HB. Impact of immune cell depletion on survival with tumor and progress of intervention and treatment with strengthening vital qi method. Hebei J Trad Chin Med. 2022;44(2):346–352.
   Google Scholar
• Cui YC, Li JQ, Zhang D. Immunotherapy of tumor. Chin J Immunol. 2022;38(14):1783–1787.
   Google Scholar
• Guo JY, Wu JC, Fang ZH. Research progress on regulation of tumor-associated macrophage by traditional Chinese medicine. Chinese Archives Traditional Chin Med. 2021;39(3):156–160.
   Google Scholar
• Xie YG, Shen KP, Lu YL. Progress in TCM treatment of non-small cell lung cancer. China J Tradition Chinese Med Pharm. 2021;36(05):2846–2851.
   Google Scholar
• Guo CH, Jiang SX. The study and utilization of lily bulb. Acta Chin Med Pharmacol. 2004;03:27–29.
   Google Scholar
• Li TZ. Development of research on lily’s functional components. Food Science and Technology. 2007;7:248–252.
   Google Scholar
• He SM, Huang QQ. Effect of Baihe Gujin Decotion with TP chemotherapy on advanced non-small cell lung carcinoma differentiated by lung-kidney yin deficiency and on the immune function. World J Integr Trad West Med. 2020;15(04):682–686.
   Google Scholar
• Li FX. Efficacy and safety of combined Chinese and Western medicine in the treatment of elderly patients with advanced non-small cell lung cancer. Chin J Contr Endemic Dis. 2017;32(05):501–502.
   Google Scholar
• Liang B, Leng BL, Zhang YX. Clinical study on shengmai decoction and baihe gujin tang for enhancing efficacy and reducing toxicity in advanced lung cancer with Qi-Yin deficiency syndrome. J New Chin Med. 2019;51(07):82–84.
   Google Scholar
• Lv TG. Occult infection of tumors and its treatment in traditional Chinese medicine. J Traditional Chin Med. 2011;52(5):382–385.
   Google Scholar
• Yang YJ, Chen J, Ma XF. Effect of ulinastatin on microcirculation indexes, inflammatory factors and cognition function in patients with acute circulatory failure caused by lung cancer co-infection. Oncol Progre. 2020;20(16):1674–1677.
   Google Scholar
• Li DF. Clinical study on the changes in serum level of cytokines among the cases of lung cancer infected with bacteria and their response to the therapy with modified herbal compound formula of bily bulb metal-securing decotion. Hunan Univ Chin Med. 2005;1:2.
   Google Scholar
• Wu QH, Wu S, Li YH, Han J. Pharmacodynamic Studies of “Baihe Gujin Tang”. J Guangd Pharma Univ. 1998;01:23–26.
   Google Scholar
• Wang L, Yan SH. Clinical study on Baihe Gujin decoction and Zhisou powder in treating lung cancer cough (lung yin deficiency syndrome). China Med Pharm. 2020;10(8):43–45,69.
   Google Scholar
• Zhu L, Sun YP, Yang J. Effect of Qingfei Jiedu Decoction and Baihe Gujin Decoction in the prevention and treatment of radio-pulmonary lesion (RP) in patients with lung cancer. Jilin J Trad Chin Med. 2022;42(07):788–791.
   PubMedGoogle Scholar
• Li CJ, Li RT. Effects of Baihe Gujin decoction combined with TP chemotherapy on tumor markers and levels of NF-κB, MMP-2 and MMP-9 in patients with advanced lung and kidney yin deficiency type non-small cell lung cancer. Clin Res Pra. 2023;8(01):115–117.
   Google Scholar
• Xie RF, Song ZY. The mechanism of Bai He Gu Jin Tang against non-small cell lung cancer revealed by network pharmacology and molecular docking. Medicine. 2022;101:52.
   Google Scholar
• Fouzder C, Mukhuty A, Kundu R. Kaempferol inhibits Nrf2 signalling pathway via downregulation of Nrf2 mRNA and induces apoptosis in NSCLC cells. Arch Biochem Biophys. 2021;697:108700.
   PubMed Web of Science ®Google Scholar
• Jo E, Park SJ, Choi YS, Jeon WK, Kim BC. Kaempferol suppresses transforming growth factor-beta1-induced epithelial-to-mesenchymal transition and migration of A549 lung cancer cells by inhibiting Akt1-mediated phosphorylation of Smad3 at threonine-179. Neoplasia. 2015;17(7):525–537.
   PubMed Web of Science ®Google Scholar
• Huang KY, Wang TH, Chen CC, et al. Growth suppression in lung cancer cells harboring EGFR-C797S mutation by quercetin. Biomolecules. 2021;11:9.
   Web of Science ®Google Scholar
• Chai R, Xu C, Lu L, Liu X, Ma Z. Quercetin inhibits proliferation of and induces apoptosis in non-small-cell lung carcinoma via the lncRNA SNHG7/miR-34a-5p pathway. Immunopharmacol Immunotoxicol. 2021;43(6):693–703.
   PubMed Web of Science ®Google Scholar
• Luo W, Liu Q, Jiang N, Li M, Shi L. Isorhamnetin inhibited migration and invasion via suppression of Akt/ERK-mediated epithelial-to-mesenchymal transition (EMT) in A549 human non-small-cell lung cancer cells. Biosci Rep. 2019;39:9.
   Web of Science ®Google Scholar
• Du Y, Jia C, Liu Y, Li Y, Wang J, Sun K. Isorhamnetin enhances the radiosensitivity of A549 cells through interleukin-13 and the NF-kappaB signaling pathway. Front Pharmacol. 2020;11:610772.
   PubMed Web of Science ®Google Scholar
• Wang Y, Xie S, Liu C, Wu Y, Liu Y, Cai Y. Inhibitory effect of liquiritigenin on migration via downregulation proMMP-2 and PI3K/Akt signaling pathway in human lung adenocarcinoma A549 cells. Nutr Cancer. 2012;64(4):627–634.
   PubMed Web of Science ®Google Scholar
• Alvarez-Sala A, Attanzio A, Tesoriere L, Garcia-Llatas G, Barbera R, Cilla A. Apoptotic effect of a phytosterol-ingredient and its main phytosterol (beta-sitosterol) in human cancer cell lines. Int J Food Sci Nutr. 2019;70(3):323–334.
   PubMed Web of Science ®Google Scholar
• Bin Sayeed MS, Ameen SS. Beta-sitosterol: a promising but orphan nutraceutical to fight against cancer. Nutr Cancer. 2015;67(8):1214–1220.
   PubMed Web of Science ®Google Scholar
• Fang L, Wang HY, Wang YN, Liu WD, Ding JL, Sun JG. Efficacy of Baihe Gujin Decoction combined with β-heptapodophylloside sodium in the treatment of acute radiation pneumonitis. Shaanxi J Trad Chin Med. 2013;12:1575–1576.
   Google Scholar
• Vundru SS, Kale RK, Singh RP. beta-Sitosterol induces G1 arrest and causes depolarization of mitochondrial membrane potential in breast carcinoma MDA-MB-231 cells. BMC Complement Altern Med. 2013;13:280.
   PubMed Web of Science ®Google Scholar
• Qinglin L, Xin W, Zhong L, Fang L, Cao G, Huang P. A study on the anti-tumor mechanism of total flavonoids from Radix Tetrastigmae against additional cell line based on COX-2-mediated Wnt/β-catenin signaling pathway. Oncotarget. 2017;8(33):54304–54319.
   PubMedGoogle Scholar
• Wang R, Deng Z, Zhu Z, et al. Kaempferol promotes non-small cell lung cancer cell autophagy via restricting Met pathway. Phytomedicine. 2023;121:155090.
   PubMed Web of Science ®Google Scholar
• Xingyu Z, Peijie M, Dan P, et al. Quercetin suppresses lung cancer growth by targeting Aurora B kinase. Cancer Med. 2016;5(11):3156–3165.
   PubMed Web of Science ®Google Scholar
• Li Q, Ren FQ, Yang CL, et al. Anti-proliferation effects of isorhamnetin on lung cancer cells in vitro and in vivo. Asian Pac J Cancer Prev. 2015;16(7):3035–3042.
   PubMedGoogle Scholar
• Wu X, Wang W, Chen Y, et al. Glycyrrhizin suppresses the growth of human NSCLC cell line HCC827 by downregulating HMGB1 level. Biomed Res Int. 2018;2018:6916797.
   PubMed Web of Science ®Google Scholar
• Liu R, He SL, Zhao YC, et al. Chinese herbal decoction based on syndrome differentiation as maintenance therapy in patients with extensive-stage small-cell lung cancer: an exploratory and small prospective cohort study. Evid Based Complement Alternat Med. 2015;2015:601067.
   PubMed Web of Science ®Google Scholar
• Jin JZ, Ren MC, Xing CS. Effective evaluate of treating radiation pneumonitis in the integrative medicine. Clin J Chinese Med. 2011;3(22):7.
   Google Scholar
• Fang L, Bai SF, Ding JL. Clinical observation on treatment of 20 cases of acute radiation-induced lung injury with baihe gujin decoction. Jiangsu J Trad Chin Med. 2009;6:34–35.
   Google Scholar
• Du QY, Li M, Wang XJ. Research progress on chemotherapy resistance-related factors in lung cancer. China Can. 2021;30(11):875–882.
   Google Scholar
• Cong SD. Therapeutic efficacy of Baihe Gujin Decoction combined with simultaneous radiotherapy in treating locally advanced non-small cell lung cancer. Mod J Integr Traditional Chinese and Western Med. 2021;30(12):1329–1333.
   Google Scholar
• Tang HC, Chen GW. Efficacy of Baihe Gujin Decoction combined with NP regimen in treating 30 cases of middle and advanced non-small cell lung cancer. J Changchun Univ Chin Med. 2011;27(04):615–616.
   Google Scholar
• Gui Y. Clinical study on treating advanced non-small cell lung cancer with Baihe Gujin decoction. Clin J Chinese Med. 2011;3(18):15–16.
   Google Scholar
• Hu HY, Cong Y. Discussion of spleen and stomach thought on the school of meng he of fei medical group. West J Trad Chin Med. 2010;23(12):3–5.
   Google Scholar
• Li DR, Cui TR, Wu H. A preliminary study of Lin Hongsheng’s academic thoughts on the identification and treatment of tumors. Chin J Inf Traditional Chin Med. 2008;06:86–87.
   Google Scholar
• Zhao W. Li Peiwen’s Experience About Treatment of Pulmonary Carcinoma. Beijing J Tradit Chinese Med. 2002;06:329–330.
   Google Scholar
• Liu XT, Wu YQ, Yang L. Clinical study on baihe gujin tang combined with docetaxe and platinum drugs for advanced non-small cell lung Cancer. J New Chin Med. 2022;54(08):146–149.
   Google Scholar
• Fang L, Wang LL, Wang HY. Efficacy of Bai He Gu Jin Tang combined with simultaneous radiotherapy in treating locally advanced non-small cell lung cancer. Shaanxi J Trad Chin Med. 2014;35(4):467–469.
   Google Scholar
• Wang MX, Kuang YX, Liu L. Effect of modified baihe gujin decoction on quality of life in lung cancer patients. J Anhui Univ Chin Med. 2012;31(6):22–24.
   Google Scholar
• Chen HP, Zheng AX. Baihe gujin decoction in the treatment of hemoptysis of lung carcinoma for 25 cases. Guang J Chin Med. 2021;36(14):2351–2353.
   Google Scholar
• Chen HP, Huang WL, Yan J. Study on hemostatic activity and mechanism of baihe gujin decoction. J Emergency Traditional Chin Med. 2020;29(4):653–656.
   Google Scholar
• Wang ZS. Analysis on modified Baihe Gujin Decoction in the treatment of lung cancer with hemoptysis: 42 cases. Clin J Trad Chin Med. 2012;24(7):635.
   Google Scholar
• Zhang YP, Wang Q. Observation on 56 cases of Baihe Gujing decoction in relieving the side effects of lung cancer radiotherapy. World Chin Med. 2016;11(7):1221–1223.
   Google Scholar
• Chen CW. Clinical efficacy and adverse reactions in the treatment of lung cancer with the modified Baihe Gujin Decoction. Strait Pharm J. 2020;32(01):149–151.
   Google Scholar
• Zhang QJ, Liu JB, Hu LM. Adverse reactions to radiation therapy for 91 cases of lung cancer with the modified Baihe Gujin Tang. J Guangxi Univ Chin Med. 2017;20(02):19–20.
   Google Scholar
• Chen LZ, Liu LP, Li MX. Observation on the adverse reactions to radiation therapy for 58 cases of lung cancer after modified Baihe Gujin Tang treatment. World Latest Med Inform. 2017;17(84):98–101.
   Google Scholar
• Cui HJ. Summary of experiences the treatment of lung cancer of Professor Zhang Daizhao based on Data Mining. China Acad Chin Med Sci. 2012;2:1.
   Google Scholar
• Zhang CY, Sun SJ, Liu YJ. Observation on the curative effect of integration of traditional Chinese medicine and western medicine for the treatment of small-cell lung cancer. China J Chin Med. 2013;28(04):481–482.
   Google Scholar
• Jin JS, Hei JZ, Zhou LM. The progress of molecular-targeted therapeutic drugs in non-small cell lung cancer. Chin J Clin Oncol. 2015;42(17):881–885.
   Google Scholar
• Qu HJ. Effect of baihe gujin decoction addition and subtraction combined with tyrosine kinase inhibitor on patients with non-small cell lung cancer. Chinese and Foreign Med Res. 2022;20(17):37–40.
   Google Scholar
• Wang X. Effect of Mai Men Dong Tang+Bai He Gu Jin Tang combined with gefitinib on immune function of elderly patients with advanced non-small cell lung cancer. Guang J Chin Med. 2020;35(03):421–423.
   Google Scholar
• Wang WM, Jin J, Zhang YL. Clinical Study of 42 Cases on ”Yiqi Jianpi Prescription” Combined with Arotinib in the Treatment of Advanced Non-small Cell Lung Cancer in Elderly Patients with Negative Driver Gene. Jiangsu J Trad Chin Med. 2021;53(10):27–30.
   Google Scholar